FindTrial
Sign In

A case records based retrospective multi-center study of clinical efficacy of radical radio-chemotherapy or neoadjuvant chemotherapy plus postoperative radiotherapy and chemotherapy for the locally advanced cervical cancer

A case records based retrospective multi-center study of clinical efficacy of radical radio-chemotherapy or neoadjuvant chemotherapy plus postoperative radiotherapy and chemotherapy for the locally advanced cervical cancer

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-PRC-16008822
Enrollment
Unknown
Registered
2016-07-11
Start date
2006-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical cancer

Interventions

Cohorts:Nil

Sponsors

China-Japan Union Hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 70 years old; 2. KPS=60; 3. Pathologically confirmed cervical cancer; 4. FIGO staging locally advanced cervical cancer (1B2/2A2/2B and above); 5. Received the radical radio-chemotherapy or neoadjuvant chemotherapy plus postoperative radiotherapy +/- concurrent chemotherapy +/- adjuvant chemotherapy; 6. The brachytherapy combined with external radiotherapy; 7. The external radiotherapy including the three-dimensional conformal external beam radiotherapy or IMRT technology; 8. The therapy ended in March 31, 2016.

Exclusion criteria

Exclusion criteria: 1. Previous or concomitant other cancers; 2. Other serious illnesses; 3. Failure to follow-up after treatment; 4. The data is missing or incomplete.

Design outcomes

Primary

MeasureTime frame
Overall Survival;Progression-Free Survival;—

Countries

China

Contacts

Public ContactCheng Guanghui

China-Japan Union Hospital of Jilin University

chengghcjuh@sina.com+86 13504334509

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026